Drug interaction between a selective serotonin reuptake inhibitor and a triptan leading to serotonin toxicity: a case report and review of the literature

被引：0

作者：

Gilbert Jin

Philip Stokes

机构：

[1] Redcliffe Hospital,

来源：

Journal of Medical Case Reports | / 15卷

关键词：

Serotonin toxicity; Serotonin reuptake inhibitors; Serotonin 5-HT1 receptor agonists; Triptans; Adverse effects; Drug interaction;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 24 条

[1]

Boyer EW(2005)The serotonin syndrome N Engl J Med 352 1112-1120

[2]

Shannon M(2007)Serotonin toxicity: a practical approach to diagnosis and treatment Med J Aust 187 361-365

[3]

Isbister GK(2007)The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and Triptans: an analysis of the 29 case reports Medscape Gen Med 9 48-642

[4]

Buckley NA(2003)The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity QJM Mon J Assoc Physicians 96 635-713

[5]

Whyte IM(1991)The serotonin syndrome Am J Psychiatry 148 705-1696

[6]

Evans RW(2008)Serotonin syndrome risks when combining SSRI/SNRI drugs and triptans: is the FDA's alert warranted? Ann Pharmacother 42 1692-1099

[7]

Dunkley EJ(2010)The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper Headache 50 1089-572

[8]

Isbister GK(2018)Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome JAMA Neurol 75 566-undefined

[9]

Sibbritt D(undefined)undefined undefined undefined undefined-undefined

[10]

Dawson AH(undefined)undefined undefined undefined undefined-undefined

← 1 2 3 →